BullMarket.com Updates Outlooks on Stem Cell Companies
23 May 2007 - 2:57AM
PR Newswire (US)
PRINCETON, N.J., May 22 /PRNewswire/ -- BullMarket.com
(http://www.bullmarket.com/), an online investment newsletter
focused on long- term growth and income-generating stocks,
announced today that it has provided subscribers with a detailed
report updating outlooks on stem cell companies including Geron
(NASDAQ:GERN), Aastrom Biosciences (NASDAQ:ASTM), and ViaCell
(NASDAQ:VIAC). All paid and trial subscribers to BullMarket.com can
now receive immediate access to the newsletter's exclusive daily
reports. As a subscriber, you'll also gain access to our latest
investment moves. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/index.php?refer=BMR240P In its
report, BullMarket.com wrote: "One event in the past year had a
significant impact on companies in this sector, like Geron, Aastrom
Biosciences, and ViaCell, and that was the results of last
November's election. These companies saw their shares increase in
value as investors figured that a Congress controlled by Democrats
would be more likely to increase federal funding for stem cell
research. So far, there has been little movement on that front as
Congress and the White House are locked in a battle over funding
for the war Iraq..." BullMarket.com looked at the following topics,
among others: -- What are the near-term catalysts, if any, for stem
cell companies? -- For investors interested in putting some money
toward the stem cell trend, which stock is the best bet? -- How is
the political climate shaping up with regard to stem cell
initiatives? About BullMarket.com: Launched in 1997, BullMarket.com
has a strong track record of creating wealth for its subscribers by
providing sound, long-term investing advice. The BullMarket.com
Recommended List includes about 50 companies across all major
industries, including Financials, Healthcare, Energy, Technology,
and Retail, among others. BullMarket.com is one of the oldest
continuously published investment newsletters online, and its
Recommended List has consistently outperformed the major market
indices. NOTE: This release was published by Indie Research
Advisors, LLC (CRD #131926), a registered investment advisor with
the NASD and State of NJ. Past performance does not guarantee
future results. Investors should always research companies and
securities before making any investments. Nothing herein should be
construed as an offer or solicitation to buy or sell any security.
CONTACT: Marcie Martin, +1-888-278-5515 DATASOURCE: Indie Research
Advisors, LLC CONTACT: Marcie Martin of Indie Research Advisors,
LLC, +1-888-278-5515 Web site: http://www.bullmarket.com/
Copyright
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jul 2023 to Jul 2024